Log in to save to my catalogue

Ethylmalonic encephalopathy and liver transplantation: long-term outcome of the first treated patien...

Ethylmalonic encephalopathy and liver transplantation: long-term outcome of the first treated patien...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4522e8f9b2db4be2bc0e579ae42707e3

Ethylmalonic encephalopathy and liver transplantation: long-term outcome of the first treated patient

About this item

Full title

Ethylmalonic encephalopathy and liver transplantation: long-term outcome of the first treated patient

Publisher

England: BioMed Central Ltd

Journal title

Orphanet journal of rare diseases, 2021-05, Vol.16 (1), p.229-9, Article 229

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Ethylmalonic encephalopathy (EE) is a severe intoxication-type metabolic disorder with multisystem clinical features and leading to early death. In 2014, based on the promising results obtained by liver-targeted gene therapy in Ethe1
mouse model, we successfully attempted liver transplantation in a 9-month-old EE girl. Here we report her long-te...

Alternative Titles

Full title

Ethylmalonic encephalopathy and liver transplantation: long-term outcome of the first treated patient

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_4522e8f9b2db4be2bc0e579ae42707e3

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4522e8f9b2db4be2bc0e579ae42707e3

Other Identifiers

ISSN

1750-1172

E-ISSN

1750-1172

DOI

10.1186/s13023-021-01867-5

How to access this item